{"meta":{"query_hash":"d5df91172dc6","filters":{"venue":"Current Biomarker Findings"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d5df91172dc6","api":"https://metacan.xera.ac/api/v1/cohort?venue=Current+Biomarker+Findings"},"results":[{"id":"W2026889359","doi":"10.2147/cbf.s39103","title":"Predicting efficacy of sunitinib in metastatic renal cell carcinoma","year":2014,"lang":"en","type":"article","venue":"Current Biomarker Findings","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Pfizer","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Oncology; Internal medicine; Cancer research","score_opus":0.05056953875250192,"score_gpt":0.29979913699251226,"score_spread":0.24922959824001034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026889359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891257,0.0062549156,0.0014890402,0.00032996738,0.000064947984,0.000054942455,0.0007553846,0.00008019477,0.0018448518],"genre_scores_gemma":[0.9982791,0.00043145992,0.00069647806,0.0000317807,0.000024991103,0.000010017259,0.0003234837,0.000002646668,0.0002000588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995315,0.000122013866,0.000070555754,0.000076966615,0.00016683013,0.000032210522],"domain_scores_gemma":[0.9988194,0.0004797145,0.0002735837,0.000032984648,0.0002388416,0.00015543573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013075138,0.00026041947,0.0007532982,0.00076076307,0.00018060706,0.0006124063,0.00022559718,0.00037153575,0.0013179033],"category_scores_gemma":[0.0024023512,0.00008187613,0.00034158622,0.00054771703,0.00012944912,0.0003491537,0.00018246575,0.00032539302,0.0003434092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021766429,0.0001843406,0.9428147,0.00019024282,0.00026899503,0.00018748784,0.000037570513,0.0030188859,0.0038540047,0.00008996897,0.0009417254,0.046235535],"study_design_scores_gemma":[0.00014315246,0.002785615,0.93960613,0.0000881149,0.0006453554,0.0021425935,0.00015771526,0.029193906,0.020346444,0.0006778622,0.0041738926,0.00003923358],"about_ca_topic_score_codex":0.0008702443,"about_ca_topic_score_gemma":0.0009591312,"teacher_disagreement_score":0.0013179033,"about_ca_system_score_codex":0.00046705324,"about_ca_system_score_gemma":0.00038974095,"threshold_uncertainty_score":0.0069149137},"labels":[],"label_agreement":null}]}